The presence or absence of cirrhosis with tumour features, including vascular invasion and portal vein thrombosis, tumour size and alpha-fetoprotein, are important prognostic indicators of HCC, which affects treatment decisions and outcomes (Al-Shamsi et al., 2017). This evidence concerns the gene AFP and Cirrhosis.